2026 Michigan Medical Device Summit™
Wednesday, September 30, 2026
Washtenaw Community College, Ann Arbor
This event is presented in partnership with
Where Michigan's Medical Device Ecosystem Connects, Innovates, and Grows
Join Michigan's premier Medical Device Summit™ to explore cutting-edge technologies, regulations, and industry insights. Network with top industry professionals, medtech innovators, researchers, manufacturing suppliers, investors, and government officials. Discover Michigan's thriving medtech ecosystem and its impact on innovation and economic growth.
REGISTER TODAY
WHY ATTEND?
Gain Strategic Insights – Learn about emerging technologies, regulatory updates, market trends, and industry best practices.
Build Valuable Connections – Network with medtech leaders, innovators, manufacturers, investors, and service providers.
Accelerate Innovation – Discover resources, partnerships, and opportunities that support product development and commercialization.
WHO SHOULD ATTEND?
Join us if you are:
- Industry executives and KOLs in the medtech sector
- Medtech product development experts
- Professionals in contract manufacturing, prototyping, or related services
- Medtech innovators
- Academic professionals engaged in medtech education
- Service specialists — regulatory, legal/IP, other providers
Be part of the conversation driving Michigan's medical technology cluster, and engage in intrastate partnering.
KEYNOTE SPEAKER
Michelle Tarver, MD, PhD
Director - Center for Devices and Radiological Health
U.S. Food & Drug Administration
Dr. Michelle Tarver is Director of the FDA's Center for Devices and Radiological Health (CDRH), where she leads the Center's efforts to advance public health through innovative, safe, and effective medical devices. A board-certified ophthalmologist with a PhD in epidemiology, she has more than 15 years of experience at the FDA, holding leadership roles spanning medical device regulations, strategic innovation, patient engagement, and evidence generation.
Throughout her career, Dr. Tarver has led initiatives to strengthen collaboration across the healthcare ecosystem, elevate the patient perspective in regulatory decision-making, and advance innovative approaches to medical device evaluation. She has extensive experience in clinical research, regulatory policy, and premarket and postmarket review.
Dr. Tarver earned a B.S. in Biochemistry from Spelman College and completed the M.D./Ph.D. program at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. She continues to practice as a clinician caring for patients with inflammatory eye conditions.
FULL Conference Agenda
Networking Breakfast
7:30-8:30 AM
Continental Breakfast, Networking, Sponsors and Exhibitors
C-Suite Unplugged: The Future of Medtech: Leading through Transformation
8:30-9:30 AM
Medical technology is entering a period of unprecedented change. AI-enabled devices, evolving regulatory expectations, shifting supply chains, and mounting pressure to demonstrate value are reshaping the industry's future. This executive leadership panel explores the strategic decisions manufacturers are making today to remain competitive and drive innovation tomorrow.
AI Across the MedTech Enterprise: Transforming Product Development,
Manufacturing and Operations
9:35-10:25 AM
Artificial intelligence is reshaping how medical technology companies bring products from concept to manufacturing. From concept generation and engineering design to product development, manufacturing operations, quality management, supply chain optimization, and business decision-making, AI is enabling organizations to streamline workflows, improve decision-making, and accelerate innovation. This session will explore practical applications, lessons learned from early adopters, and where AI is delivering value today while examining where the greatest opportunities lie ahead.
Networking Break
10:25-10:55 AM
MedTech Spotlight, Networking, Sponsors and Exhibitors
Track Sessions | 10:55-11:45 AM
Strategy & Commercialization
The Customer Speaks: Healthcare's Unmet Needs and the Next Generation of Medical Technologies
What clinical and operational problems still need solving? In this unique "reverse pitch" session, healthcare leaders, physicians, and investors discuss the unmet needs, technology gaps, and emerging opportunities they believe deserve the attention of medical device innovators. Rather than companies pitching solutions, attendees will hear directly from prospective customers and investors about where they see the greatest need - and opportunity - for innovation.
Technology & Manufacturing
Building Strategic Partnerships with CMOs, CDMOs and Suppliers
Successful medical device companies engage manufacturing and supply chain partners well before production begins. This session explores how startups, OEMs, contract manufacturers, and suppliers collaborate throughout product realization - from design for manufacturability and supplier qualification to design transfer, quality system alignment, manufacturing scale-up, and long-term strategic partnerships.
LUNCH, PLENARY Keynote Session, NETWORKING, Sponsors and EXHIBITORS
11:45 AM-1:15 PM
Advancing Innovation, Ensuring Trust: A Conversation with FDA CDRH Director Dr. Michelle Tarver
As medical technology becomes increasingly sophisticated - from AI-enabled diagnostics and digital therapeutics to connected devices and advanced manufacturing - the role of regulatory leadership has never been more critical. Join the Director of the FDA's Center for Devices and Radiological Health (CDRH), for an engaging fireside chat exploring the agency's vision for fostering innovation while ensuring patient safety and public confidence. The discussion will examine emerging regulatory priorities, the future of AI oversight, opportunities to accelerate patient access to breakthrough technologies, and how FDA is partnering with industry to shape the next generation of medical devices.
Track Sessions | 1:15-2:00 PM
Strategy & Commercialization
Commercialization Playbook: From Regulatory Clearance to Market Success
Regulatory clearance is a major milestone - but it is only the beginning of commercialization. Industry leaders will discuss the strategies required to successfully launch and scale medical technologies, including commercialization planning, market positioning, pricing strategy, customer engagement, distribution, commercialization execution, and operational growth.
Technology & Manufacturing
Beyond the Device: Essential Technical Services for Market Readiness
Successfully bringing a medical device to market requires far more than product design and manufacturing. Companies must navigate a broad range of specialized technical services - from sterilization and packaging validation to microbiology testing, biocompatibility, electrical safety certification, labeling, environmental testing, and other regulatory compliance activities. This session will explore how these specialized services fit into the product development process, when they should be incorporated, and how early planning can reduce risk, avoid costly delays, and support successful commercialization.
Track Sessions | 2:05-2:50 PM
Strategy & Commercialization
Reimbursement Roadmap: Coding, Coverage and Payment Strategies for Medtech
Reimbursement planning should begin long before product launch. This session examines how medical device companies develop successful coding, coverage, and payment strategies, generate clinical and economic evidence, and navigate CMS and commercial payer requirements to support adoption and long-term commercial success.
Technology & Manufacturing
Cybersecurity in Medtech: Protecting Products, Patients and Companies
Cybersecurity is no longer just an IT issue - it is a product development, quality, regulatory, and business imperative. As cyber threats continue to evolve, and regulatory expectations become more rigorous, medical device companies must strengthen cybersecurity throughout the product lifecycle. This session will examine current FDA cybersecurity requirements, emerging global regulations, vulnerability management, incident response, and lessons learned from recent cybersecurity events.
Networking Break
2:50-3:20 PM
MedTech Spotlight, Networking, Sponsors and Exhibitors
Michigan's MedTech Manufacturing Advantage: Strengthening Michigan's Competitive Edge
3:20-4:05 PM
Michigan possesses many of the assets needed to lead the next generation of medical technology innovation - from advanced manufacturing and engineering talent to research excellence and startup leadership. This session examines how strategic collaboration among industry, academia, healthcare, and economic development organizations can further strengthen the state's competitive advantage in the global medtech economy.
MedTech at a Crossroads: Policy, Politics, and the Fight for Innovation
4:10-5:00 PM
From FDA reform and reimbursement pressures to global competition and supply chain security, public policy decisions are increasingly determining which technologies reach patients—and which companies thrive. This session examines the legislative, regulatory, and advocacy priorities shaping the future of the medical technology industry, while providing a forward-looking perspective on the policy issues likely to influence innovation, investment, manufacturing, and patient access in the years ahead.
